Entering text into the input field will update the search result below

Agenus earns $2M milestone from Merck antibody selection

Jun. 09, 2016 9:35 AM ETAgenus Inc. (AGEN) StockMRK, AGENBy: Douglas W. House, SA News Editor6 Comments
  • Agenus (AGEN -0.2%earns its first milestone from collaboration partner Merck (MRK -0.1%). The $2M payment was triggered by Merck's selection of a lead antibody candidate and several backup antibodies, discovered by Agenus, to an undisclosed Merck checkpoint target.
  • Merck will be responsible for all future product development costs related to the candidate. Agenus is eligible to receive up to $100M in future milestones in addition to royalties on global net sales.
  • The companies inked their partnership to discover therapeutic antibodies to immune checkpoints for the treatment of cancer in April 2014.

Recommended For You

About AGEN Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
AGEN--
Agenus Inc.